CIK 0001672688
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Absci Corp
Sign in to watch- Ticker
- ABSI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 853383487
- Phone
- +1 360-949-1041
- Business address
- 18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
- Former names
- AbSci, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-12 | Redmile Group, LLC Director | Grant or award | +8,820 | 8,262,136 | ||
| 2024-06-12 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +36,274 | 36,274 | ||
| 2024-03-01 | Redmile Group, LLC Director | Purchase | +222,222 | $4.50 | $1000K | 8,253,316 |
| 2023-06-14 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +53,100 | 53,100 | ||
| 2022-06-08 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +28,700 | 28,700 | ||
| 2021-07-26 | Redmile Group, LLC Director | Conversion | +4,209,573 | 4,209,573 | ||
| 2021-07-26 | Redmile Group, LLC Director | Conversion | +1,946,521 | 6,156,094 | ||
| 2021-07-26 | Redmile Group, LLC Director | Purchase | +1,875,000 | $16.00 | $30.0M | 8,031,094 |
| 2021-07-26 | Redmile Group, LLC Director | Conversion · Series E Convertible Preferred Stock | −4,209,573 | 0 | ||
| 2021-07-26 | Redmile Group, LLC Director | Conversion · Convertible Promissory Note | −0 | 0 |
Page 1 of 1 · 10 trades